Chinese vaccine maker to extend trial to teenagers, children
Sinovac Biotech plans to test its experimental Covid-19 vaccine on younger subjects in a new trial, Reuters reported.
The company is looking to recruit 552 subjects between 3 and 17 years old to receive two shots of either a placebo injection or CoronaVac, Sinovac’s inactivated vaccine in the new Phase 1/2 study that is slated to begin at the end of this month.
Beijing-based Sinovac is only one of a handful of Chinese companies racing to develop a Covid-19 vaccine. CoronaVac is already in Phase 3 testing in several countries, such as Brazil and Indonesia. The company also recently revealed that a large majority of its own employees and their family have taken its vaccine.
The company is looking to recruit 552 subjects between 3 and 17 years old to receive two shots of either a placebo injection or CoronaVac, Sinovac’s inactivated vaccine in the new Phase 1/2 study that is slated to begin at the end of this month.
Beijing-based Sinovac is only one of a handful of Chinese companies racing to develop a Covid-19 vaccine. CoronaVac is already in Phase 3 testing in several countries, such as Brazil and Indonesia. The company also recently revealed that a large majority of its own employees and their family have taken its vaccine.
.png)
No hay comentarios:
Publicar un comentario